Previous close | 109.01 |
Open | 68.99 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 62.40 - 70.97 |
52-week range | 62.40 - 138.89 |
Volume | |
Avg. volume | 2,732 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 1.30 |
EPS (TTM) | 0.49 |
Earnings date | 24 Oct 2024 - 28 Oct 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The Federal Reserve's preferred inflation gauge, the Personal Consumption Expenditures (PCE) index, showed prices rising at its slowest rate in over three years while core PCE data came largely in-line with expectations. Seana Smith and Jared Blikre help investors start the day off right, highlighting the biggest market stories this morning as the three major averages (^DJI, ^IXIC, ^GSPC) digest the June PCE print. Bank of America Securities head of US economics Michael Gapen joins the program to shine a light on how the Fed may be looking at the June PCE data, alongside other recent inflation prints, in terms of its interest rate cut strategy. Bernstein senior analyst Daniel Roeska also sits down with The Morning Brief team to cover the auto industry's earnings performance this week, including Tesla (TSLA) and Stellantis (STLA). Other top trending tickers on the Yahoo Finance platform include the 3M Company (MMM), Deckers Outdoor (DECK), DexCom (DXCM), Norfolk Southern (NSC), and Coursera (COUR). This post was written by Luke Carberry Mogan.
DexCom (DXCM) stock plummets Friday morning — carrying into the market open — after missing second quarter revenue estimates and lowering its full-year revenue guidance. The company manufactures and distributes glucose monitoring systems used in treating diabetes. Seana Smith and Jared Blikre break down DexCom's earnings figures, how GLP-1 weight-loss drug trends may be impacting it, and how analyst teams are reassessing their outlook on the stock. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
Dexcom stock plummeted early Friday after the diabetes devices maker reported light June-quarter sales and slashed its outlook.